Literature DB >> 11149563

The role of chemokines and chemokine receptors in mucosal inflammation.

K A Papadakis1, S R Targan.   

Abstract

Chemokines represent a large family of small cytokines, the main function of which is the attraction of leukocytes to different tissues. Several chemokines and their receptors have been shown to play a critical role in lymphoid development, mucosal immunity, and inflammation. In this article we review recent advances in chemokine physiology and their potential role in the pathogenesis of mucosal inflammation. We also discuss the potential for the use of chemokine or chemokine receptor antagonists as novel therapies for inflammatory bowel disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11149563     DOI: 10.1002/ibd.3780060408

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  31 in total

1.  Regulation of alpha1-proteinase inhibitor release by proinflammatory cytokines in human intestinal epithelial cells.

Authors:  D Faust; K Raschke; S Hormann; V Milovic; J Stein
Journal:  Clin Exp Immunol       Date:  2002-05       Impact factor: 4.330

2.  RNA aptamers selected against the receptor activator of NF-kappaB acquire general affinity to proteins of the tumor necrosis factor receptor family.

Authors:  Tadashi Mori; Akihiro Oguro; Takashi Ohtsu; Yoshikazu Nakamura
Journal:  Nucleic Acids Res       Date:  2004-11-23       Impact factor: 16.971

Review 3.  Chemokines in inflammatory bowel disease.

Authors:  S Danese; A Gasbarrini
Journal:  J Clin Pathol       Date:  2005-10       Impact factor: 3.411

4.  Rho activation regulates CXCL12 chemokine stimulated actin rearrangement and restitution in model intestinal epithelia.

Authors:  Rebecca A Moyer; Michael K Wendt; Priscilla A Johanesen; Jerrold R Turner; Michael B Dwinell
Journal:  Lab Invest       Date:  2007-06-18       Impact factor: 5.662

5.  Expression Profiling of Inflammatory and Immunological Genes in Collagenous Colitis.

Authors:  Qingqing Liu; Noam Harpaz
Journal:  J Crohns Colitis       Date:  2019-05-27       Impact factor: 9.071

6.  Increased expression of interleukin 17 in inflammatory bowel disease.

Authors:  S Fujino; A Andoh; S Bamba; A Ogawa; K Hata; Y Araki; T Bamba; Y Fujiyama
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

7.  CCR6 regulation of the actin cytoskeleton orchestrates human beta defensin-2- and CCL20-mediated restitution of colonic epithelial cells.

Authors:  Rebecca A Vongsa; Noah P Zimmerman; Michael B Dwinell
Journal:  J Biol Chem       Date:  2009-02-20       Impact factor: 5.157

8.  Autologous adipose tissue-derived stem cells for the treatment of complex perianal fistulas not associated with Crohn's disease: a phase II clinical trial for safety and efficacy.

Authors:  S Choi; S-B Ryoo; K J Park; D-S Kim; K-H Song; K H Kim; S S Chung; E J Shin; Y B Cho; S T Oh; W-K Kang; M H Kim
Journal:  Tech Coloproctol       Date:  2017-05-31       Impact factor: 3.781

Review 9.  Chemokines and chemokine receptors in mucosal homeostasis at the intestinal epithelial barrier in inflammatory bowel disease.

Authors:  Noah P Zimmerman; Rebecca A Vongsa; Michael K Wendt; Michael B Dwinell
Journal:  Inflamm Bowel Dis       Date:  2008-07       Impact factor: 5.325

10.  Polymorphisms of the macrophage inflammatory protein 1 alpha and ApoE genes are associated with ulcerative colitis.

Authors:  Keshen Li; Binyou Wang; Hong Sui; Shengyuan Liu; Songpo Yao; Liang Guo; Dongwei Mao
Journal:  Int J Colorectal Dis       Date:  2008-09-02       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.